ERBB2 and neoplasm: The synthesized Z HER2:342-QD conjugates exhibited tumor-targeting ability with superior imaging contrast in mice bearing HER2-overexpressing SKOV3 tumors compared to low-level HER2-expressing PC-3 mice.